Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Trial of Trastuzumab Deruxtecan With Stereotactic Radiosurgery (SRS) in Participants With Brain Metastases From HER-2 Positive Breast Cancer

NCT07454668 is registered in ClinicalTrials.gov with Baptist Health South Florida as lead sponsor.

NCT NCT07454668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07454668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Trial of Trastuzumab Deruxtecan With Stereotactic Radiosurgery (SRS) in Participants With Brain Metastases From HER-2 Positive Breast Cancer
Lead sponsor
Baptist Health South Florida
Phase
Phase 1
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
February 28, 2030
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases, breast cancer, cancer, cancer metastatic, her2-positive breast cancer